Combined anti-cd40 conditioning and well-timed immunization prolongs cd8+ T Cell Accumulation and Control of Established Brain Tumors

Christina M. Ryan, Kevin Staveley-O'Carroll, Todd D. Schell

Research output: Contribution to journalArticle

7 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)380-384
Number of pages5
JournalJournal of Immunotherapy
Volume31
Issue number9
DOIs
StatePublished - Jan 1 2008

Fingerprint

Brain Neoplasms
Immunotherapy
Immunization
Vaccination
T-Lymphocytes

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology
  • Pharmacology
  • Cancer Research

Cite this

@article{ad8e946c892344ccacda79955aab9e8d,
title = "Combined anti-cd40 conditioning and well-timed immunization prolongs cd8+ T Cell Accumulation and Control of Established Brain Tumors",
author = "Ryan, {Christina M.} and Kevin Staveley-O'Carroll and Schell, {Todd D.}",
year = "2008",
month = "1",
day = "1",
doi = "10.1097/CJI.0b013e318189f155",
language = "English (US)",
volume = "31",
pages = "380--384",
journal = "Journal of Immunotherapy",
issn = "1524-9557",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

Combined anti-cd40 conditioning and well-timed immunization prolongs cd8+ T Cell Accumulation and Control of Established Brain Tumors. / Ryan, Christina M.; Staveley-O'Carroll, Kevin; Schell, Todd D.

In: Journal of Immunotherapy, Vol. 31, No. 9, 01.01.2008, p. 380-384.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Combined anti-cd40 conditioning and well-timed immunization prolongs cd8+ T Cell Accumulation and Control of Established Brain Tumors

AU - Ryan, Christina M.

AU - Staveley-O'Carroll, Kevin

AU - Schell, Todd D.

PY - 2008/1/1

Y1 - 2008/1/1

UR - http://www.scopus.com/inward/record.url?scp=85026148521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026148521&partnerID=8YFLogxK

U2 - 10.1097/CJI.0b013e318189f155

DO - 10.1097/CJI.0b013e318189f155

M3 - Article

C2 - 18832997

AN - SCOPUS:85026148521

VL - 31

SP - 380

EP - 384

JO - Journal of Immunotherapy

JF - Journal of Immunotherapy

SN - 1524-9557

IS - 9

ER -